The trial results provided inconclusive evidence of the efficacy of RFA of DRG in the treatment of cervicogenic headaches. For cervicobrachial pain, there is only short term pain relief with both ...

Pharmacological treatment options are divided into abortive and preventative ... strong evidence-base for the diagnosis and management in hypermobile patients. Cervicogenic headache is a secondary ...

Mental stress in the workspace can also impact workers physically and if left unchecked, can trigger neuro-musculoskeletal disorders including migraine, tension and cervicogenic ... pain with possible ...

A team of international researchers including those from the University of Adelaide have taken a well-known chemical reaction ...

While many people living with chronic pain require medication, there is growing interest in non-pharmacological approaches ...

Mindfulness meditation and pain reprocessing therapy can reduce chronic pain by addressing the emotion-related factors that ...

The FDA has approved Nerivio REN to include the acute and/or preventive treatment of migraine in patients 8 years of age and older.

Monthly 140 mg erenumab injections are a safe and effective treatment for patients with nonopioid chronic migraine and medication overuse headaches.

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...